Target intelligence / Profile preview

Bacterial 30S ribosomal subunit – initiation factor binding interface

Molecular classification
Ribosomal subunit, Protein-RNA complex, Translation initiation machinery, Enzyme
01

Overview

The bacterial 30S ribosomal subunit – initiation factor binding interface is a specialized region on the small ribosomal subunit where the essential initiation factors IF1, IF2, and IF3 bind to coordinate the start of protein synthesis (NIH, 2023). This interface facilitates the recruitment of the initiator formyl-methionine transfer RNA (fMet-tRNA) to the ribosomal P-site and ensures the accurate selection of the mRNA start codon (Wikipedia, 2024). IF3 plays a dual role by checking the fidelity of the codon-anticodon interaction and preventing the premature association of the 50S subunit until the initiation complex is correctly formed (NIH, 2023). This site is a potent target for various antibiotics, including kasugamycin and the specialized inhibitor GE81112, which block the formation of a functional 70S ribosome (PNAS, 2011). Because the translation initiation pathway is one of the most divergent processes between bacteria and eukaryotes, targeting this interface offers high selectivity for antimicrobial therapy (NIH, 2019). Disruption of this interface effectively halts bacterial growth by preventing the synthesis of all new proteins (PatSnap, 2024). This target is particularly relevant in the context of multi-drug resistant infections, as it represents an underexploited site for novel antibiotic development (NIH, 2015).

Other names
30S initiation factor binding site30S-IF interface30S initiation complex interfaceProkaryotic 30S ribosomal subunit initiation site30S IC interface
02

Mechanism of action

Inhibition of translation initiation by blocking fMet-tRNA binding, interfering with start codon recognition, or preventing the assembly of the 70S ribosome.

03

Biological functions

Translation initiationStart codon selectionfMet-tRNA recruitmentRibosome assemblyRibosome recycling
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistanceMitochondrial ribosome toxicityOtotoxicityNephrotoxicity
06

Interacting drugs

GE81112

10 more in the full profile.

07

Biomarkers

Bacterial loadPathogen identification16S rRNA sequencing

Beyond the preview

Go deeper on Bacterial 30S ribosomal subunit – initiation factor binding interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 30S ribosomal subunit – initiation factor binding interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call